chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Chalazion, Pyrexia
Clinical narrative: left eye chalazion/I had a reaction on my left top eye lid and pimple emrgedstill have 2 chalazions on left eye; low grade fever,; This spontaneous case was reported by a consumer and describes the occurrence of CHALAZION (left eye chalazion/I had a reaction on my left top eye lid and pimple emrgedstill have 2 chalazions on left eye) and PYREXIA (low grade fever,) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     Concurrent medical conditions included Asthma. Concomitant products included ATORVASTATIN and FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (WIXELA INHUB) for an unknown indication.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form(s). On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Apr-2021, the patient experienced PYREXIA (low grade fever,). On 21-Apr-2021, the patient experienced CHALAZION (left eye chalazion/I had a reaction on my left top eye lid and pimple emrgedstill have 2 chalazions on left eye). The patient was treated with CALCIUM at an unspecified dose and frequency. At the time of the report, CHALAZION (left eye chalazion/I had a reaction on my left top eye lid and pimple emrgedstill have 2 chalazions on left eye) and PYREXIA (low grade fever,) outcome was unknown.            This case was linked to MOD-2021-086442 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Treatment drug and concomitant drugs were added along with other relevant history
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Influenza, Limb discomfort, Pharyngeal erythema, Posture abnormal
Clinical narrative: Just wants to sleep/Eyes just want to close; Redness in throat; Limbs heavy; Can fall asleep in any position; Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), SOMNOLENCE (Just wants to sleep/Eyes just want to close), PHARYNGEAL ERYTHEMA (Redness in throat), LIMB DISCOMFORT (Limbs heavy) and POSTURE ABNORMAL (Can fall asleep in any position) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced DIARRHOEA (Diarrhea). On 18-Apr-2021, the patient experienced SOMNOLENCE (Just wants to sleep/Eyes just want to close), PHARYNGEAL ERYTHEMA (Redness in throat), LIMB DISCOMFORT (Limbs heavy) and POSTURE ABNORMAL (Can fall asleep in any position). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DIARRHOEA (Diarrhea), SOMNOLENCE (Just wants to sleep/Eyes just want to close), PHARYNGEAL ERYTHEMA (Redness in throat), LIMB DISCOMFORT (Limbs heavy) and POSTURE ABNORMAL (Can fall asleep in any position) outcome was unknown. Not Related    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Apr-2021, Influenza: negative (Negative) Negative. On 20-Apr-2021, SARS-CoV-2 test: negative (Negative) Negative. On 20-Apr-2021, Streptococcus test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Somnolence, Streptococcus test
Clinical narrative: Just wants to sleep/Eyes just want to close; Redness in throat; Limbs heavy; Can fall asleep in any position; Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), SOMNOLENCE (Just wants to sleep/Eyes just want to close), PHARYNGEAL ERYTHEMA (Redness in throat), LIMB DISCOMFORT (Limbs heavy) and POSTURE ABNORMAL (Can fall asleep in any position) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced DIARRHOEA (Diarrhea). On 18-Apr-2021, the patient experienced SOMNOLENCE (Just wants to sleep/Eyes just want to close), PHARYNGEAL ERYTHEMA (Redness in throat), LIMB DISCOMFORT (Limbs heavy) and POSTURE ABNORMAL (Can fall asleep in any position). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DIARRHOEA (Diarrhea), SOMNOLENCE (Just wants to sleep/Eyes just want to close), PHARYNGEAL ERYTHEMA (Redness in throat), LIMB DISCOMFORT (Limbs heavy) and POSTURE ABNORMAL (Can fall asleep in any position) outcome was unknown. Not Related    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Apr-2021, Influenza: negative (Negative) Negative. On 20-Apr-2021, SARS-CoV-2 test: negative (Negative) Negative. On 20-Apr-2021, Streptococcus test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dizziness, Dyspepsia, Feeling abnormal, Hypokinesia
Clinical narrative: Itchy; Felt as sword went in her shoulder blade; Injected arm was swollen; She had to call her husband to come and get her because she couldn't drive; Extreme heartburn; Throat felt like it was closing; Felt dizzy/felt like room was spinning; Thought she was dying so she got scared; This spontaneous case was reported by a consumer and describes the occurrence of DYSPEPSIA (Extreme heartburn), OROPHARYNGEAL DISCOMFORT (Throat felt like it was closing), DIZZINESS (Felt dizzy/felt like room was spinning), FEELING ABNORMAL (Thought she was dying so she got scared) and PRURITUS (Itchy) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Multiple sclerosis.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 15-Apr-2021, the patient experienced DYSPEPSIA (Extreme heartburn), DIZZINESS (Felt dizzy/felt like room was spinning), FEELING ABNORMAL (Thought she was dying so she got scared) and HYPOKINESIA (She had to call her husband to come and get her because she couldn't drive). 15-Apr-2021, the patient experienced OROPHARYNGEAL DISCOMFORT (Throat felt like it was closing). On 16-Apr-2021, the patient experienced PRURITUS (Itchy), ARTHRALGIA (Felt as sword went in her shoulder blade) and INJECTION SITE SWELLING (Injected arm was swollen). The patient was treated with CALCIUM CARBONATE (TUMS [CALCIUM CARBONATE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, DYSPEPSIA (Extreme heartburn), OROPHARYNGEAL DISCOMFORT (Throat felt like it was closing), DIZZINESS (Felt dizzy/felt like room was spinning), FEELING ABNORMAL (Thought she was dying so she got scared), HYPOKINESIA (She had to call her husband to come and get her because she couldn't drive) and ARTHRALGIA (Felt as sword went in her shoulder blade) outcome was unknown and PRURITUS (Itchy) and INJECTION SITE SWELLING (Injected arm was swollen) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included multiple sclerosis medicine, Blood Pressure medicine and bone medicine.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling, Oropharyngeal discomfort, Pruritus
Clinical narrative: Itchy; Felt as sword went in her shoulder blade; Injected arm was swollen; She had to call her husband to come and get her because she couldn't drive; Extreme heartburn; Throat felt like it was closing; Felt dizzy/felt like room was spinning; Thought she was dying so she got scared; This spontaneous case was reported by a consumer and describes the occurrence of DYSPEPSIA (Extreme heartburn), OROPHARYNGEAL DISCOMFORT (Throat felt like it was closing), DIZZINESS (Felt dizzy/felt like room was spinning), FEELING ABNORMAL (Thought she was dying so she got scared) and PRURITUS (Itchy) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Multiple sclerosis.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 15-Apr-2021, the patient experienced DYSPEPSIA (Extreme heartburn), DIZZINESS (Felt dizzy/felt like room was spinning), FEELING ABNORMAL (Thought she was dying so she got scared) and HYPOKINESIA (She had to call her husband to come and get her because she couldn't drive). 15-Apr-2021, the patient experienced OROPHARYNGEAL DISCOMFORT (Throat felt like it was closing). On 16-Apr-2021, the patient experienced PRURITUS (Itchy), ARTHRALGIA (Felt as sword went in her shoulder blade) and INJECTION SITE SWELLING (Injected arm was swollen). The patient was treated with CALCIUM CARBONATE (TUMS [CALCIUM CARBONATE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, DYSPEPSIA (Extreme heartburn), OROPHARYNGEAL DISCOMFORT (Throat felt like it was closing), DIZZINESS (Felt dizzy/felt like room was spinning), FEELING ABNORMAL (Thought she was dying so she got scared), HYPOKINESIA (She had to call her husband to come and get her because she couldn't drive) and ARTHRALGIA (Felt as sword went in her shoulder blade) outcome was unknown and PRURITUS (Itchy) and INJECTION SITE SWELLING (Injected arm was swollen) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included multiple sclerosis medicine, Blood Pressure medicine and bone medicine.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: sore arm in the injection site arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm in the injection site arm) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 043L20A and 025J20-2) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Feb-2021, the patient experienced VACCINATION SITE PAIN (sore arm in the injection site arm). At the time of the report, VACCINATION SITE PAIN (sore arm in the injection site arm) outcome was unknown. Not Provided          No concomitant and treatment medications were reported.    This case was linked to MOD-2021-086321 (Patient Link).
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Pruritus, Vaccination site erythema, Vaccination site rash
Clinical narrative: little bit shoulder itchy; skin broke up a little bit/He thought has a reaction to the shot; rash on his skin, like redness/He thought has a reaction to the shot; Is not a painful issue but is kind of worried little bit; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (little bit shoulder itchy), VACCINATION SITE RASH (skin broke up a little bit/He thought has a reaction to the shot), VACCINATION SITE ERYTHEMA (rash on his skin, like redness/He thought has a reaction to the shot) and ANXIETY (Is not a painful issue but is kind of worried little bit) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045A21A and 023M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRURITUS (little bit shoulder itchy), VACCINATION SITE RASH (skin broke up a little bit/He thought has a reaction to the shot), VACCINATION SITE ERYTHEMA (rash on his skin, like redness/He thought has a reaction to the shot) and ANXIETY (Is not a painful issue but is kind of worried little bit). At the time of the report, PRURITUS (little bit shoulder itchy), VACCINATION SITE RASH (skin broke up a little bit/He thought has a reaction to the shot), VACCINATION SITE ERYTHEMA (rash on his skin, like redness/He thought has a reaction to the shot) and ANXIETY (Is not a painful issue but is kind of worried little bit) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Age don't match with DOB Action taken with mRNA-1273 in response to the events was  not applicable No concomitant medications were given No treatment information was provided
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Aching) and FATIGUE (Extremely fatigued) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032B21A and 011A21A) for COVID-19 vaccination. The patient's past medical history included Infusion (Entyvio (vedolizumab) infusion every week) since an unknown date. Concurrent medical conditions included Crohn's disease. On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced FATIGUE (Extremely fatigued). On an unknown date, the patient experienced PAIN (Aching). At the time of the report, PAIN (Aching) and FATIGUE (Extremely fatigued) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable. No concomitant medication reported. No treatment medication reported.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pain
Clinical narrative: Felt achiness on his leg on the same side; An achy arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Felt achiness on his leg on the same side) and VACCINATION SITE PAIN (An achy arm) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced PAIN IN EXTREMITY (Felt achiness on his leg on the same side). 27-Mar-2021, the patient experienced VACCINATION SITE PAIN (An achy arm). At the time of the report, PAIN IN EXTREMITY (Felt achiness on his leg on the same side) and VACCINATION SITE PAIN (An achy arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment medication was not provided.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Pain in extremity
Clinical narrative: Chest pain; Arm pain; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Chest pain) and PAIN IN EXTREMITY (Arm pain) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, the patient experienced CHEST PAIN (Chest pain) and PAIN IN EXTREMITY (Arm pain). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, CHEST PAIN (Chest pain) and PAIN IN EXTREMITY (Arm pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Headache, Nasal congestion, Nasopharyngitis
Clinical narrative: Felt like a really nasty head cold for about 3 days: plugged up, couldn't breath, stuffy; Felt like a really nasty head cold for about 3 days: plugged up, couldn't breath, stuffy; Felt like a really nasty head cold for about 3 days: plugged up, couldn't breath, stuffy; had a headache; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Felt like a really nasty head cold for about 3 days: plugged up, couldn't breath, stuffy), DYSPNOEA (Felt like a really nasty head cold for about 3 days: plugged up, couldn't breath, stuffy), NASAL CONGESTION (Felt like a really nasty head cold for about 3 days: plugged up, couldn't breath, stuffy) and HEADACHE (had a headache) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included LISINOPRIL, CARVEDILOL, FENOFIBRATE (ADIPEX [FENOFIBRATE]), SIMVASTATIN, TADALAFIL (CIALIS), FUROSEMIDE, SPIRONOLACTONE, ACETYLSALICYLIC ACID (BABY ASPIRIN), ASCORBIC ACID (VIT C) and MULTIVITAMIN [ASCORBIC ACID;COLECALCIFEROL;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL;RIBOFLAVIN;THIAMINE HYDROCHLORIDE] for an unknown indication.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced NASOPHARYNGITIS (Felt like a really nasty head cold for about 3 days: plugged up, couldn't breath, stuffy), DYSPNOEA (Felt like a really nasty head cold for about 3 days: plugged up, couldn't breath, stuffy), NASAL CONGESTION (Felt like a really nasty head cold for about 3 days: plugged up, couldn't breath, stuffy) and HEADACHE (had a headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 26-Mar-2021, NASOPHARYNGITIS (Felt like a really nasty head cold for about 3 days: plugged up, couldn't breath, stuffy), DYSPNOEA (Felt like a really nasty head cold for about 3 days: plugged up, couldn't breath, stuffy), NASAL CONGESTION (Felt like a really nasty head cold for about 3 days: plugged up, couldn't breath, stuffy) and HEADACHE (had a headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-086187, US-MODERNATX, INC.-MOD-2021-085661, US-MODERNATX, INC.-MOD-2021-085677 (E2B Linked Report). This case was linked to MOD-2021-086668 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 14-May-2021: Contact information updated. On 17-May-2021: non-significant follow up On 25-May-2021: Non-significant follow-up appended; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-086187:father case for dose 2 US-MODERNATX, INC.-MOD-2021-085661:wife case for dose 1 US-MODERNATX, INC.-MOD-2021-085677:wife case for dose 2
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, COVID-19
Clinical narrative: got Covid but she did not mention if it was before or after first shot; cannot feel her taste 100%; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (got Covid but she did not mention if it was before or after first shot) and AGEUSIA (cannot feel her taste 100%) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (got Covid but she did not mention if it was before or after first shot) and AGEUSIA (cannot feel her taste 100%). At the time of the report, COVID-19 (got Covid but she did not mention if it was before or after first shot) and AGEUSIA (cannot feel her taste 100%) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications provided No treatment medications provided
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure abnormal, Blood pressure measurement, Dizziness, Flushing, Headache
Clinical narrative: Hypersensitivity reaction; Blood presure 162/102; Flushed; Sweaty; Lightheaded; Headache; This spontaneous case was reported by a nurse and describes the occurrence of HYPERSENSITIVITY (Hypersensitivity reaction), BLOOD PRESSURE ABNORMAL (Blood presure 162/102), FLUSHING (Flushed), HYPERHIDROSIS (Sweaty) and DIZZINESS (Lightheaded) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes. Concomitant products included INSULIN for an unknown indication.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced FLUSHING (Flushed), HYPERHIDROSIS (Sweaty), DIZZINESS (Lightheaded) and HEADACHE (Headache). On an unknown date, the patient experienced HYPERSENSITIVITY (Hypersensitivity reaction) and BLOOD PRESSURE ABNORMAL (Blood presure 162/102). At the time of the report, HYPERSENSITIVITY (Hypersensitivity reaction), BLOOD PRESSURE ABNORMAL (Blood presure 162/102), FLUSHING (Flushed), HYPERHIDROSIS (Sweaty), DIZZINESS (Lightheaded) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Apr-2021, Blood pressure measurement: 162/102 mmHg (Inconclusive) 162/102. On 12-Apr-2021, Heart rate: 105 (Inconclusive) 105. On 12-Apr-2021, Oxygen saturation: 98% (Inconclusive) 98%. On an unknown date, Blood pressure measurement: 142/104 mmHg (Inconclusive) on discharge. On an unknown date, Heart rate: 80 (Inconclusive) on discharge.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details were not provided.   This case was linked to MODERNATX, INC.-MOD-2021-021697, MODERNATX, INC.-MOD-2021-022231, MODERNATX, INC.-MOD-2021-023928, MODERNATX, INC.-MOD-2021-023864 (E2B Linked Report).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Follow-up information received on 30-Apr-2021 contains non-significant information On 24-May-2021: Follow-up information received on 24-May-2021 : VAERS, patients initials, Batch number of vaccine, AE details, concomitant medications On 29-Jul-2021: Follow up contains no significant information.; Sender's Comments:  MODERNATX, INC.-MOD-2021-021697:Crosslink MODERNATX, INC.-MOD-2021-022231:Crosslink MODERNATX, INC.-MOD-2021-023928:Crosslink MODERNATX, INC.-MOD-2021-023864:Crosslink
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Hyperhidrosis, Hypersensitivity, Oxygen saturation
Clinical narrative: Hypersensitivity reaction; Blood presure 162/102; Flushed; Sweaty; Lightheaded; Headache; This spontaneous case was reported by a nurse and describes the occurrence of HYPERSENSITIVITY (Hypersensitivity reaction), BLOOD PRESSURE ABNORMAL (Blood presure 162/102), FLUSHING (Flushed), HYPERHIDROSIS (Sweaty) and DIZZINESS (Lightheaded) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes. Concomitant products included INSULIN for an unknown indication.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced FLUSHING (Flushed), HYPERHIDROSIS (Sweaty), DIZZINESS (Lightheaded) and HEADACHE (Headache). On an unknown date, the patient experienced HYPERSENSITIVITY (Hypersensitivity reaction) and BLOOD PRESSURE ABNORMAL (Blood presure 162/102). At the time of the report, HYPERSENSITIVITY (Hypersensitivity reaction), BLOOD PRESSURE ABNORMAL (Blood presure 162/102), FLUSHING (Flushed), HYPERHIDROSIS (Sweaty), DIZZINESS (Lightheaded) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Apr-2021, Blood pressure measurement: 162/102 mmHg (Inconclusive) 162/102. On 12-Apr-2021, Heart rate: 105 (Inconclusive) 105. On 12-Apr-2021, Oxygen saturation: 98% (Inconclusive) 98%. On an unknown date, Blood pressure measurement: 142/104 mmHg (Inconclusive) on discharge. On an unknown date, Heart rate: 80 (Inconclusive) on discharge.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details were not provided.   This case was linked to MODERNATX, INC.-MOD-2021-021697, MODERNATX, INC.-MOD-2021-022231, MODERNATX, INC.-MOD-2021-023928, MODERNATX, INC.-MOD-2021-023864 (E2B Linked Report).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Follow-up information received on 30-Apr-2021 contains non-significant information On 24-May-2021: Follow-up information received on 24-May-2021 : VAERS, patients initials, Batch number of vaccine, AE details, concomitant medications On 29-Jul-2021: Follow up contains no significant information.; Sender's Comments:  MODERNATX, INC.-MOD-2021-021697:Crosslink MODERNATX, INC.-MOD-2021-022231:Crosslink MODERNATX, INC.-MOD-2021-023928:Crosslink MODERNATX, INC.-MOD-2021-023864:Crosslink
Age: 35.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Contusion, Migraine, Motion sickness, Nausea, Rash
Clinical narrative: Bruise; Car sickness; Migraine; Itchy rash; Red rash; Painful rash; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (Bruise), MOTION SICKNESS (Car sickness), MIGRAINE (Migraine), RASH PRURITIC (Itchy rash) and RASH ERYTHEMATOUS (Red rash) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Crohn's disease.    No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced CONTUSION (Bruise), MOTION SICKNESS (Car sickness), MIGRAINE (Migraine), RASH PRURITIC (Itchy rash), RASH ERYTHEMATOUS (Red rash), RASH (Painful rash) and NAUSEA (Nausea). At the time of the report, CONTUSION (Bruise), MOTION SICKNESS (Car sickness), MIGRAINE (Migraine), RASH PRURITIC (Itchy rash), RASH ERYTHEMATOUS (Red rash), RASH (Painful rash) and NAUSEA (Nausea) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not Applicable. No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Age: 35.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Rash erythematous, Rash pruritic
Clinical narrative: Bruise; Car sickness; Migraine; Itchy rash; Red rash; Painful rash; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (Bruise), MOTION SICKNESS (Car sickness), MIGRAINE (Migraine), RASH PRURITIC (Itchy rash) and RASH ERYTHEMATOUS (Red rash) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Crohn's disease.    No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced CONTUSION (Bruise), MOTION SICKNESS (Car sickness), MIGRAINE (Migraine), RASH PRURITIC (Itchy rash), RASH ERYTHEMATOUS (Red rash), RASH (Painful rash) and NAUSEA (Nausea). At the time of the report, CONTUSION (Bruise), MOTION SICKNESS (Car sickness), MIGRAINE (Migraine), RASH PRURITIC (Itchy rash), RASH ERYTHEMATOUS (Red rash), RASH (Painful rash) and NAUSEA (Nausea) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not Applicable. No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Tinnitus
Clinical narrative: High pitched ringing on ears; Headache; dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), TINNITUS (High pitched ringing on ears) and HEADACHE (Headache) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006B21A and 038A21A) for COVID-19 vaccination.     Concomitant products included CLONAZEPAM for an unknown indication.   On 19-Mar-2021 at 2:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021 at 2:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Apr-2021, the patient experienced DIZZINESS (dizziness) and HEADACHE (Headache). On 21-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced TINNITUS (High pitched ringing on ears). The patient was treated with IBUPROFEN ongoing since an unknown date for Adverse event, at an unspecified dose and frequency. At the time of the report, DIZZINESS (dizziness) and HEADACHE (Headache) had resolved and TINNITUS (High pitched ringing on ears) had not resolved. Ringing  seems to be more on the right side of patient's head/ear.          This case was linked to US-MODERNATX, INC.-MOD-2021-085912 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 22-May-2021: Follow up was received on 22-MAY-2021. Patient demographics- height, weight and race were added. Vaccination times for both doses were added. Vaccine facility information and concomitant medication- clonazepam were also added. Additional events- headache and dizziness were added. On 22-May-2021: Follow up received on 22-MAY-2021 contains no new information with respect to the patient; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-085912:Case for Daughter (MOD21-080096)
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Hyperhidrosis, Hypersomnia
Clinical narrative: fatigue; hypersomnolence; alert and sweaty; This spontaneous case was reported by a health care professional and describes the occurrence of FATIGUE (fatigue), HYPERSOMNIA (hypersomnolence) and HYPERHIDROSIS (alert and sweaty) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On an unknown date, the patient experienced FATIGUE (fatigue), HYPERSOMNIA (hypersomnolence) and HYPERHIDROSIS (alert and sweaty). At the time of the report, FATIGUE (fatigue), HYPERSOMNIA (hypersomnolence) and HYPERHIDROSIS (alert and sweaty) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       N0 concomitant medications are provided by the reporter. treatment to the events not reported.   This case was linked to MOD-2021-086001 (E2B Linked Report).; Sender's Comments:  MOD-2021-086001:Patient case
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Chalazion, Pyrexia
Clinical narrative: Right eye chalazion; low-grade fever; This spontaneous case was reported by a consumer and describes the occurrence of CHALAZION (Right eye chalazion) and PYREXIA (low-grade fever) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     Concurrent medical conditions included Asthma. Concomitant products included ATORVASTATIN and FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (WIXELA INHUB) for an unknown indication.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Mar-2021, the patient experienced PYREXIA (low-grade fever). On 21-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced CHALAZION (Right eye chalazion). The patient was treated with DEXAMETHASONE, TOBRAMYCIN (TOBRAMYCIN + DEXAMETHASONE) at an unspecified dose and frequency and AMOXICILLIN at a dose of 500 mg. At the time of the report, CHALAZION (Right eye chalazion) and PYREXIA (low-grade fever) had resolved.            This case was linked to MOD-2021-086328 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Updated reporter details, updated patient demographics, updated medical history, updated concomitant medications, updated treatment medications and changed outcome of the event chalazion from unknown to recovered/resolved.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Influenza like illness, Lymphadenopathy
Clinical narrative: Swollen lymph nodes; Weakness; Flu like symptoms; This spontaneous case was reported by an other and describes the occurrence of LYMPHADENOPATHY (Swollen lymph nodes), ASTHENIA (Weakness) and INFLUENZA LIKE ILLNESS (Flu like symptoms) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    The patient's past medical history included COVID-19 on 15-Feb-2021. Concurrent medical conditions included Rheumatoid arthritis (Moderate to severe.).   In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced LYMPHADENOPATHY (Swollen lymph nodes), ASTHENIA (Weakness) and INFLUENZA LIKE ILLNESS (Flu like symptoms). At the time of the report, LYMPHADENOPATHY (Swollen lymph nodes) and ASTHENIA (Weakness) outcome was unknown and INFLUENZA LIKE ILLNESS (Flu like symptoms) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant and treatment medications were not reported.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Gave the vaccine past the 12 hours it is supposed to be outside) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination. No medical history was provided by the reporter. On 20-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Gave the vaccine past the 12 hours it is supposed to be outside). On 21-Apr-2021, EXPIRED PRODUCT ADMINISTERED (Gave the vaccine past the 12 hours it is supposed to be outside) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were provided. No treatment medications were provided.; Sender's Comments: This report refers to a case of Expired Product Administered for mRNA-1273 (Lot #: 045A21A)  with no associated AEs.
Age: 55.0
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: 2nd Moderna Vaccine given > 42 days past 1st Vaccine; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd Moderna Vaccine given > 42 days past 1st Vaccine) in a 55-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd Moderna Vaccine given > 42 days past 1st Vaccine). On 22-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd Moderna Vaccine given > 42 days past 1st Vaccine) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication information was provided No treatment medication information was provided
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature increased, Pain in extremity
Clinical narrative: little Sore Arm; A little Temperature (After the First Shot); This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (little Sore Arm) and BODY TEMPERATURE INCREASED (A little Temperature (After the First Shot)) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced BODY TEMPERATURE INCREASED (A little Temperature (After the First Shot)). On an unknown date, the patient experienced PAIN IN EXTREMITY (little Sore Arm). On 17-Mar-2021, BODY TEMPERATURE INCREASED (A little Temperature (After the First Shot)) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-086570 (Patient Link).
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Extreme Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Extreme Fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Type 2 diabetes mellitus.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (Extreme Fatigue). At the time of the report, FATIGUE (Extreme Fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication not provided. Concomitant medication not provided.   This case was linked to MOD-2021-079043 (E2B Linked Report).; Sender's Comments:  MOD-2021-079043:2nd dose
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (lymph node in clavicle area became very enlarged and swollen/ lymph node swelling in the clavicle area) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 011J20A) for COVID-19 vaccination. Concurrent medical conditions included Migraine, Drug allergy (Allergy to erythromycin (stomach upset) reported.), Drug allergy (Allergy to codeine (hives) reported.) and Allergy (Allergy to medical tape (hives) reported.). Concomitant products included ESTRADIOL for Hormone therapy, ALMOTRIPTAN MALATE (AXERT) for Migraine, FEXOFENADINE HYDROCHLORIDE (ALLEGRA) and FLUTICASONE for Seasonal allergy. On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced LYMPHADENOPATHY (lymph node in clavicle area became very enlarged and swollen/ lymph node swelling in the clavicle area). On 01-Mar-2021, LYMPHADENOPATHY (lymph node in clavicle area became very enlarged and swollen/ lymph node swelling in the clavicle area) had resolved. Treatment information not reported. This case was linked to MOD-2021-007607. Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: Follow up received and concomitant medication was added.
Age: 62.0
Sex: U
Vaccine: COVID19
Symptoms: Vaccination error
Clinical narrative: vaccine leaked on administration; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION ERROR (vaccine leaked on administration) in a 62-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, the patient experienced VACCINATION ERROR (vaccine leaked on administration). At the time of the report, VACCINATION ERROR (vaccine leaked on administration) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concomitant medication and treatment information provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site pruritus
Clinical narrative: Minor Sore Injection Site (After the SECOND Shot); Minor Itchy Injection Site (After the SECOND Shot); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Minor Sore Injection Site (After the SECOND Shot)) and VACCINATION SITE PRURITUS (Itchy Injection Site (After the SECOND Shot)) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced VACCINATION SITE PAIN (Minor Sore Injection Site (After the SECOND Shot)). On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Itchy Injection Site (After the SECOND Shot)). On 14-Apr-2021, VACCINATION SITE PAIN (Minor Sore Injection Site (After the SECOND Shot)) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant products were not provided. Treatment products were not provided.    This case was linked to MOD-2021-086483 (Patient Link).
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Hypoaesthesia, Hypokinesia, Musculoskeletal stiffness, Pain in extremity
Clinical narrative: itching / still get itchy; hands are stiff; cannot move my second finger on right hand; both legs are numb; bit swollen; dizziness; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), PAIN IN EXTREMITY (sore arm), PRURITUS (itching / still get itchy), MUSCULOSKELETAL STIFFNESS (hands are stiff) and HYPOKINESIA (cannot move my second finger on right hand) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     patients has a history of taking blood thinners.  The patient's past medical history included Diabetes.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 02-Apr-2021, the patient experienced DIZZINESS (dizziness) and PAIN IN EXTREMITY (sore arm). On 03-Apr-2021, the patient experienced PRURITUS (itching / still get itchy), MUSCULOSKELETAL STIFFNESS (hands are stiff), HYPOKINESIA (cannot move my second finger on right hand), HYPOAESTHESIA (both legs are numb) and PERIPHERAL SWELLING (bit swollen). At the time of the report, DIZZINESS (dizziness), PAIN IN EXTREMITY (sore arm), PRURITUS (itching / still get itchy), MUSCULOSKELETAL STIFFNESS (hands are stiff), HYPOKINESIA (cannot move my second finger on right hand), HYPOAESTHESIA (both legs are numb) and PERIPHERAL SWELLING (bit swollen) outcome was unknown. Not Provided          Reporter did not allow further contact
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Pruritus
Clinical narrative: itching / still get itchy; hands are stiff; cannot move my second finger on right hand; both legs are numb; bit swollen; dizziness; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), PAIN IN EXTREMITY (sore arm), PRURITUS (itching / still get itchy), MUSCULOSKELETAL STIFFNESS (hands are stiff) and HYPOKINESIA (cannot move my second finger on right hand) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     patients has a history of taking blood thinners.  The patient's past medical history included Diabetes.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 02-Apr-2021, the patient experienced DIZZINESS (dizziness) and PAIN IN EXTREMITY (sore arm). On 03-Apr-2021, the patient experienced PRURITUS (itching / still get itchy), MUSCULOSKELETAL STIFFNESS (hands are stiff), HYPOKINESIA (cannot move my second finger on right hand), HYPOAESTHESIA (both legs are numb) and PERIPHERAL SWELLING (bit swollen). At the time of the report, DIZZINESS (dizziness), PAIN IN EXTREMITY (sore arm), PRURITUS (itching / still get itchy), MUSCULOSKELETAL STIFFNESS (hands are stiff), HYPOKINESIA (cannot move my second finger on right hand), HYPOAESTHESIA (both legs are numb) and PERIPHERAL SWELLING (bit swollen) outcome was unknown. Not Provided          Reporter did not allow further contact